Dan Polen - Polen Capital Management
Holding/activity history for Ascendis Pharma (ASND)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,812 | <0.01 | Add 49.63% | <0.01 | $228.73 | $414,459 | SEC |
| 2025 Q4 | 1,211 | <0.01 | Reduce 56.22% | <0.01 | $213.24 | $258,234 | SEC |
| 2025 Q3 | 2,766 | <0.01 | Add 1.73% | $198.81 | $549,908 | SEC | |
| 2025 Q2 | 2,719 | <0.01 | Buy | <0.01 | $172.60 | $469,299 | SEC |